Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Greene

Showing results (901-910 of 1,076) with videos related to

Pageof 108
Sort By:
The Journal of Biological Chemistry|January 12, 2007
CD1d degradation in Chlamydia trachomatis-infected epithelial cells is the result of both cellular and chlamydial proteasomal activityKei Kawana, Alison J Quayle, Mercedes Ficarra, et al.
Circulation. Heart Failure|October 31, 2022
In-Hospital Virtual Peer-to-Peer Consultation to Increase Guideline-Directed Medical Therapy for Heart Failure: A Pilot Randomized TrialVishal N Rao, Anand Shah, Jaime McDermott, et al.
JAMA|March 13, 2013
Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trialMihai Gheorghiade, Michael Böhm, Stephen J Greene, et al.
Circulation. Heart Failure|May 4, 2016
Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST TrialAndrew P Ambrosy, Hassan Khan, James E Udelson, et al.
American Heart Journal|December 6, 2019
Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure?Marat Fudim, Jacob P Kelly, Aaron D Jones, et al.
Neuron|May 25, 2019
Loss of Adaptive Myelination Contributes to Methotrexate Chemotherapy-Related Cognitive ImpairmentAnna C Geraghty, Erin M Gibson, Reem A Ghanem, et al.
Cell Reports|August 16, 2018
Three Distinct Sets of Connector Hubs Integrate Human Brain FunctionEvan M Gordon, Charles J Lynch, Caterina Gratton, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 26, 2026
Temporal trends and projections in Hypertension with Substance Use-related mortality, 1999-2035: Insights from the CDC WONDER databaseSaifullah Khan, Arham Kamil, Nisha Khalid, et al.
Physical Review Letters|July 30, 2002
Unexpected behavior of heavy-ion fusion cross sections at extreme sub-barrier energiesC L Jiang, H Esbensen, K E Rehm, et al.
JACC. Heart Failure|March 14, 2014
The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trialStephen J Greene, Muthiah Vaduganathan, Jane E Wilcox, et al.
Pageof 108

Showing results (901-910 of 1,076) with videos related to

Sort By:
Pageof 108
The Journal of Biological Chemistry|January 12, 2007
CD1d degradation in Chlamydia trachomatis-infected epithelial cells is the result of both cellular and chlamydial proteasomal activityKei Kawana, Alison J Quayle, Mercedes Ficarra, et al.
Circulation. Heart Failure|October 31, 2022
In-Hospital Virtual Peer-to-Peer Consultation to Increase Guideline-Directed Medical Therapy for Heart Failure: A Pilot Randomized TrialVishal N Rao, Anand Shah, Jaime McDermott, et al.
JAMA|March 13, 2013
Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trialMihai Gheorghiade, Michael Böhm, Stephen J Greene, et al.
Circulation. Heart Failure|May 4, 2016
Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST TrialAndrew P Ambrosy, Hassan Khan, James E Udelson, et al.
American Heart Journal|December 6, 2019
Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure?Marat Fudim, Jacob P Kelly, Aaron D Jones, et al.
Neuron|May 25, 2019
Loss of Adaptive Myelination Contributes to Methotrexate Chemotherapy-Related Cognitive ImpairmentAnna C Geraghty, Erin M Gibson, Reem A Ghanem, et al.
Cell Reports|August 16, 2018
Three Distinct Sets of Connector Hubs Integrate Human Brain FunctionEvan M Gordon, Charles J Lynch, Caterina Gratton, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 26, 2026
Temporal trends and projections in Hypertension with Substance Use-related mortality, 1999-2035: Insights from the CDC WONDER databaseSaifullah Khan, Arham Kamil, Nisha Khalid, et al.
Physical Review Letters|July 30, 2002
Unexpected behavior of heavy-ion fusion cross sections at extreme sub-barrier energiesC L Jiang, H Esbensen, K E Rehm, et al.
JACC. Heart Failure|March 14, 2014
The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trialStephen J Greene, Muthiah Vaduganathan, Jane E Wilcox, et al.
Pageof 108